Eurofarma Peru S.A.C. is the Peruvian subsidiary of Eurofarma, a Brazilian multinational pharmaceutical company. It operates in the pharmaceutical and medicine manufacturing sector with its head office in Lima, Peru. The company, originally established as Refasa Carrion and present in Peru for over 50 years, was acquired by Eurofarma in March 2013. The unit operates its own production plant and employs approximately 237 people (2024), with a broad portfolio covering prescription drugs, over-the-counter products, and dermatological/cosmeceutical lines across specialties including gastroenterology, gynecology, neurology, pediatrics, pulmonology, and psychiatry.
| Import | Export |
|---|---|
|
Trade Records
513
|
Trade Records
32
|
|
Suppliers
18
|
Buyers
3
|
|
Latest Import Date
2026-07
|
Latest Export Date
2026-07
|
According to Topease's global trade data, EUROFARMA PERU S.A.C. exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the EUROFARMA PERU S.A.C. distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, EUROFARMA PERU S.A.C. sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore EUROFARMA PERU S.A.C.'s import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| EUROFARMA LABORATORIOS S A | EUROFARMA PERU S.A.C. | 2821 | 24 | $186,500 | 3,420 | Los Angeles |
| EUROFARMA URUGUAY S.A. | EUROFARMA PERU S.A.C. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| EUROFARMA ARGEBTINA S A | EUROFARMA PERU S.A.C. | 2940 | 24 | $186,500 | 3,420 | Los Angeles |
| PROCESOS DE MANUFACTURA S.A.S. | EUROFARMA PERU S.A.C. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| LABORATOIRES ARKOPHARMA | EUROFARMA PERU S.A.C. | 2106 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into EUROFARMA PERU S.A.C.'s export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| EUROFARMA S A | EUROFARMA PERU S.A.C. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| EUROFARMA PERU S.A.C. | EUROFARMA PERU S.A.C. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| EUROFARMA VENEZUELA CASA DE REPRESE | EUROFARMA PERU S.A.C. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore EUROFARMA PERU S.A.C.'s trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access EUROFARMA PERU S.A.C.'s key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.